BsUFA III: Could Regulatory Science Research Emerge With Other Tweaks?

 
• By Derrick Gingery
  
User Fee Reauthorization Preview 2020
BsUFA III could be designed to help boost growth of the US biosimilar industry. • Source: Pink Sheet Illustration
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from User Fees

More from Pathways & Standards